Literature DB >> 8068393

Controlled comparison of the characteristics of patients with panic disorder.

R J Simpson1, T Kazmierczak, K G Power, D M Sharp.   

Abstract

BACKGROUND: Increased general practice attendance rates have been associated with the diagnosis of mental illness but panic disorder has not been specifically investigated in this respect. In addition, studies have failed adequately to assess type and frequency of secondary care referral and patterns of psychotropic prescription in patients with panic disorder in relation to matched controls. AIM: This study set out to compare subjects with panic disorder with age and sex matched controls on measures of general practice consultation rate; psychotropic and non-psychotropic drug use; referral to secondary care, laboratory and radiological tests and hospital admissions; history of illness and complaints; and psychiatric comorbidity.
METHOD: The study was carried out in nine practices in the Forth Valley area. One hundred patients with panic disorder, previously diagnosed using DSM III-R criteria, were identified and matched by age and sex with controls. Data were collected by review of general practice case notes.
RESULTS: Subjects with panic disorder had significantly higher rates of general practice consultation over the 10 year period prior to DSM III-R diagnosis of panic disorder than controls. Subjects with panic disorder had also been prescribed a significantly greater number of psychotropic and non-psychotropic medications over this period, had had more secondary care investigations and had higher rates of mainly minor illness and related complaints than controls. High comorbidity of panic disorder with depression which had been diagnosed over the 10 year period prior to DSM III-R diagnosis of panic disorder was found.
CONCLUSION: The results of this study describe a population of subjects with panic disorder who are long-term heavy users of primary care services. The results also suggest an association between panic disorder and both minor illness and psychiatric comorbidity over the 10 year period prior to DSM III-R diagnosis of panic disorder.

Entities:  

Mesh:

Year:  1994        PMID: 8068393      PMCID: PMC1238951     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  21 in total

1.  Epidemiology of anxiety.

Authors:  I M Marks
Journal:  Soc Psychiatry       Date:  1986

2.  Phobic anxiety and ischaemic heart disease.

Authors:  A P Haines; J D Imeson; T W Meade
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

Review 3.  Panic disorder and somatization. Review of 55 cases.

Authors:  W Katon
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

4.  Use of mental health services for the treatment of panic disorder.

Authors:  J H Boyd
Journal:  Am J Psychiatry       Date:  1986-12       Impact factor: 18.112

5.  Use of general medical care services by persons with mental disorders.

Authors:  J R Hankin; D M Steinwachs; D A Regier; B J Burns; I D Goldberg; E W Hoeper
Journal:  Arch Gen Psychiatry       Date:  1982-02

6.  A survey of psychotropic drug prescribing.

Authors:  W G Irwin; M E Cupples
Journal:  J R Coll Gen Pract       Date:  1986-08

7.  Excess mortality in panic disorder. A comparison with primary unipolar depression.

Authors:  W Coryell; R Noyes; J Clancy
Journal:  Arch Gen Psychiatry       Date:  1982-06

8.  Psychological treatment in general practice: its effect on patients and their families.

Authors:  R Blakey
Journal:  J R Coll Gen Pract       Date:  1986-05

9.  Screening for psychiatric illness in general practice: the general practitioner versus the screening questionnaire.

Authors:  D Goldberg; K Bridges
Journal:  J R Coll Gen Pract       Date:  1987-01

10.  Controlled clinical trial of mepiprazole in irritable bowel syndrome.

Authors:  G Dotevall; E Groll
Journal:  Br Med J       Date:  1974-10-05
View more
  9 in total

1.  The Role of Experiential Avoidance in the Relation between Anxiety Disorder Diagnoses and Future Physical Health Symptoms in a Community Sample of Young Adult Women.

Authors:  Christopher R Berghoff; Matthew T Tull; David DiLillo; Terri Messman-Moore; Kim L Gratz
Journal:  J Contextual Behav Sci       Date:  2017-01

2.  Health care use and quality of life among patients with asthma and panic disorder.

Authors:  Jonathan M Feldman; Paul M Lehrer; Soo Borson; Teal S Hallstrand; Mahmood I Siddique
Journal:  J Asthma       Date:  2005-04       Impact factor: 2.515

3.  Case-control study of GP attendance rates by suicide cases with or without a psychiatric history.

Authors:  K Power; C Davies; V Swanson; D Gordon; H Carter
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

4.  Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care.

Authors:  D M Sharp; K G Power; R J Simpson; V Swanson; J A Anstee
Journal:  Br J Gen Pract       Date:  1997-03       Impact factor: 5.386

5.  Reducing therapist contact in cognitive behaviour therapy for panic disorder and agoraphobia in primary care: global measures of outcome in a randomised controlled trial.

Authors:  D M Sharp; K G Power; V Swanson
Journal:  Br J Gen Pract       Date:  2000-12       Impact factor: 5.386

6.  GP frequent attendance in Liverpool and Granada: the impact of depressive symptoms.

Authors:  C F Dowrick; J A Bellón; M J Gómez
Journal:  Br J Gen Pract       Date:  2000-05       Impact factor: 5.386

7.  When anxiety symptoms masquerade as medical symptoms: what medical specialists know about panic disorder and available psychological treatments.

Authors:  Ellen J Teng; Angelic D Chaison; Sara D Bailey; Joseph D Hamilton; Nancy Jo Dunn
Journal:  J Clin Psychol Med Settings       Date:  2008-10-15

8.  Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management.

Authors:  Jeff C. Huffman; Mark H. Pollack; Theodore A. Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-04

Review 9.  Diagnosis and treatment of agoraphobia with panic disorder.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.